We analyzed the polyadenylated mRNAs transcribed from the cottontail rabbit papillomavirus genomes present in the domestic rabbit transplantable carcinoma line VX2, employing a combination of Si nuclease mapping and primer extension techniques with vector M13-based single-stranded DNA probes. Each of the two major mRNA species (1,860 and 1,110 bases long) contained two exons which corresponded to the E6-E7 and E2-E4 open reading frames. The splice donor site for these transcripts was located at position 1371 at the beginning of the El open reading frame. Consequently, the splicing event did not lead to the fusion of the E region proximal (E6 and E7) and distal (E2, E4, or E5) open reading frames. The translation of the polycistronic RNA could result in the production of E6 and E7 proteins alone or of an additional El-E4 fusion product if translation reinitiation can occur after the E7 stop codon. A heterogeneity was detected in the 5' ends of the longer transcript; E6 transcripts could thus yield a full-length or a truncated E6 protein. We also detected a minor subset of mRNAs covering the E2-E4 coding region and including at least three species with estimated sizes of 4.2, 2.8, and 1.8 kilobases. All the viral transcripts detected in the VX2 tumor cells were polyadenylated at the same site (position 4367) 20 base pairs beyond the first AATAAA signal which borders the E region.
Papillomaviruses induce abnormal cellular proliferation in the stratified epithelia of a wide variety of vertebrates. These benign lesions (papillomas) generally regress but may in some cases undergo malignant transformation (for a review, see reference 14) . Tumors induced by the cottontail rabbit papillomavirus (CRPV) have long been studied as a model system for this papilloma-to-carcinoma progression (16, 20) .
Early observations have shown that under natural and experimental conditions, CRPV induces warts on wild cottontail rabbits, and after a lag period of several months about 25% of the wart carriers develop metastasizing squamous cell carcinoma. Papillomas are also observed after CRPV infection of domestic rabbits, in which malignant conversion is observed in up to 75% of carriers (20) . Repeated application of carcinogenic hydrocarbons after virus infection also enhances the frequency and shortens the lag period required for malignant conversion (17) . The viral genome is present (4, 5, 21, 22) and transcriptionally active in both primary carcinomas (12, 13) and transplantable carcinoma lines which have been maintained in domestic rabbits for more than 40 years (5) . Taken together, these studies suggest that expression of the papillomavirus functions is a necessary but insufficient cause for the multistep process of malignant epithelial tumor formation and that this expression acts synergistically with exogenous (environmental) and endogenous (genetic) factors (5) .
The genetic structure of four papillomaviruses, including CRPV, has been determined by DNA sequencing (2; I. Giri, 0. Danos, and M. Yaniv, Proc. Natl. Acad. Sci. U.S.A., in press). The genome is about 8 kilobase pairs long, and its organization is remarkably conserved among viruses that infect different species. Comparative analysis of the sequences has allowed the definition of a common arrangement of the open translation frames in two regions, L for structural genes and E for transformation and replication * Corresponding author.
genes (2) . Up to now, attempts to detect E gene products in in vitro-transformed cells or in tumor tissue have been unsuccessful. Thus, the nature and functions of the viral proteins involved in the oncogenic process are still unknown. The transplantable carcinoma lines induced by CRPV (7, 15) provide a convenient system for tackling this problem. Among them, the VX2 line is non-virus-producing, corresponds to an advanced stage of malignancy, and frequently metastasizes in the lungs. From 10 to 20 copies of the CRPV genome are found integrated in the chromosomes of the tumor cells, and only their E region is transcribed, producing two spliced mRNA species of 1.25 and 2.0 kilobases (5, 12, 13 ). An identical transcription pattern is observed in primary carcinomas directly induced by the virus (13) . These mRNAs contain information from the E6-E7 coding region linked with the 3' third of the overlapping E2 and E4 open reading frames (5) . In the absence of mapping data at the nucleotide level, it was not possible to deduce the pritnary structure of the polypeptides coded by these mRNAs, as multiple combinations between E6, E7, E2, and E4 were possible.
In this paper we describe the fine mapping of the viral transcripts found in VX2 (7) . By using M13 single-stranded DNA probes labeled with 32p to high specific activities, we were also able to detect minor and previously uncharacterized transcripts present at one to five copies each in the tumor cell. This analysis allows us to report the precise structure of the mRNAs and therefore to deduce the nature of their translation products.
MATERIALS AND METHODS
Tumors and RNA preparations. The transplantable VX2 carcinoma was propagated in New Zealand domestic rabbits (4) . Polyadenylated [poly(A)+] RNAs were purified from the tumor tissue as previously described (5) .
Preparation of 32P-labeled single-stranded DNA probes. The DNA probes used for the nuclease mapping and primer Reactions were stopped by phenol addition and subjected to electrophoresis and autoradiography as described in the preceding section. Dideoxy sequencing-reaction products from the M13 clone used for the synthesis of the primer were run on the same gel to allow direct determination of the 5' end positions.
RESULTS
The VX2 transplantable carcinoma line has been shown to express two major viral mRNAs of estimated sizes 1.25 and 2.0 kilobases (kb) (5, 12, 13) . They are transcribed from the E region of the CRPV genome which contains putative genes (open reading frames) likely to be involved in viral DNA replication and cellular transformation (Giri et al., in press). The mature mRNAs contain two exons, and the sequences encoding the largest open reading frame (El) are spliced out (5, 12) . The aim of this study has been to define the structure of these transcripts at the nucleotide level and therefore to be able to deduce the nature of the viral proteins expressed in the carcinomas.
Since the viral transcripts are present at low levels in tumor cells [-5 poly(A)+ RNA molecules in 105 molecules, 15 to 30 poly(A)+ molecules per cell (5)], we chose to use a sensitive method for their detection, i.e., 32P-labeled singlestranded M13 DNA probes containing a specific CRPV sequence (see above). Such probes allowed us to distinguish fully protected from incompletely digested probe in nuclease mapping experiments. This is due to the M13 polylinker and primer sequences present at the 5' extremity which are not homologous to the viral mRNA sequences and are thus removed by the S1 nuclease. Since these probes were uniformly labeled, S1-protected fragments could be generated by either 5' or 3' ends of partially overlapping RNA. To overcome this ambiguity, we used in parallel two different probes produced from the same clone but cut with two different restriction enzymes. Comparison of the protected products with the two probes allowed unambiguous definition of the 5' and 3' ends of the RNA. The various probes used in this study and their coordinates are listed in Table 1 .
Mapping of the mRNA cap sites. Figure 1 shows the result of a nuclease protection (panel A, lane a) and a primer extension (panel B, lane c) experiment. These experiments were done with probes from the M13 clone CR516 which cover the 5' terminal region of the E6 open reading frame (see Table 1 and diagram on Fig. 1 ). S1 digestion with the clone CR516 EcoRV probe yielded two fragments, 222 and 152 nucleotides long. The observed bands represented 5' extremities, as they were also observed when clone CR516 cut with Hinfl (position 7821) was used as a probe (data not shown). Two specific bands were consistently observed in the primer extension experiments with CR516 PstI as primer. The main one corresponded to an elongation of the primer from the PstI site (position 261) to positions 157 through 159, i.e., 3' to the first ATG start codon of the E6 reading frame at position 154. The minor band indicated a start at position 87. The concordance of the results with both techniques allowed us to conclude that these were genuine 5' ends (cap sites) for viral mRNAs and that a short leader sequence is not spliced to them. These 5' ends corresponded to the 2-kb mRNA which has been shown in electron microscopy studies to cover the entire E6 region (5).
The 5' extremities of the 1.25-kb mRNA were mapped by using M13 clone CR548 cut with BamHI or PstI for S1 Fig. 2A) and with HhaI for primer extension (Fig.  2B) . The main group of microheterogeneous 5' ends was located between positions 903 and 908; they produced the ladder of bands observed with the BamHI-cut probe (panel A, lane a). Such a pattern arises from the superposition of the 5' microheterogeneity and S1 nuclease staggering at both ends of the duplex. The primer extension data (panel B) were more definitive, showing four main bands at positions 903, 904, 907, and 908. A second group of 5' ends was observed with the PstI probe (panel A, lane c) (and on shorter gel runs with the BamHI probe) which yielded protected fragments 94 and 99 bases long. Weak bands also appeared in the primer extension experiment 95 to 100 bases above the primer end. These bands were more readily detectable when clone CR548 cut with RsaI (position 1049) was used as the primer (not shown). Thus, a second set of 5' ends was observed for the 1.25-kb mRNA between positions 970 and 975.
In nuclease mapping experiments, a fraction of the probe was entirely protected (Fig. 2) . This was due to the presence of the 2.0-kb mRNA which also covers this region. As already reported (5, 12), we observed (Fig. 2) that the 1.25-kb mRNA was at least three times more abundant than the other one.
3' end of the first exon. The S1 analysis (Fig. 3 ) allowed us to map the splice donor sequence for the viral mRNAs. Using two probes (clone CR231 cut with HindIII or HhaI), a common site for the E6-and E7-containing RNAs was observed at position 1371 (see diagram and legend to Fig. 3 for details). The splice donor fell 3' to the E7 stop codon (position 1357) and 9 base pairs after the first ATG codon of the El open reading frame. The donor sequence is found at the same location (i.e., inside the El coding segment) in all four papillomaviruses whose DNA sequences have been established (Fig. 4) . The conserved pentanucleotide AGGTA (position 1370 on CRPV) includes a GGT glycine codon. The conserved usage of this codon out of four possible ones is probably related to the splicing signal, since other conserved residues in the El polypeptide are generally specified by different codons among the four viruses (e.g., the alanine residue in the second position of El).
Borders of the second exon and minor transcripts. By using probe CR42 cut with Hinfl (Fig. 5) or HhaI (not shown), it was possible to localize the splice acceptor for the major viral transcripts. We identified nucleotide 3714 as the start of the second exon. The acceptor sequence found just upstream [(Py)13 GTCACCAG/C 3714] matched the established consensus (10) . Longer exposure of the autoradiograms also revealed minor bands corresponding to the use of acceptor sequences at positions 3745 (CCCCTGAAG) and 3760 (TCCCGAAG). This would be consistent with the data of Nasseri and Wettstein (12) , who observed two 5' ends for the second exon, separated by about 50 base pairs. However, this second group of acceptor sites would only be used due to self-annealing and polymerization of the primer. The positions of the primer and the main extension products (arrows) are shown. The CRPV sequence of the coding strand between positions 152 and 161 is shown, and the first ATG of the E6 gene is framed. The autoradiogram showed that a fraction of the CR42 probe (about 5%) was entirely protected (Fig. 5) . This indicated that one or several transcripts contained sequences from upstream of the acceptor site used for the major species, possibly covering the whole E2 coding region (see Fig. 7 of several probes located between positions 3000 and 3500 on the genome to visualize this minor set of mRNAs on Northern blots; one such analysis was done with probe CR218 (Fig. 6) . At least three transcripts were detected in this region (Fig. 7) , and their approximate sizes, estimated on agarose denaturing gels, were 4.2, 2.8, and 1.8 kb.
The E region of CRPV is terminated by two polyadenylation signals (AATAAA at positions 4348 and 4438). The S1 analysis with probe CR51 cut by HhaI or SphI yielded protected fragments of 159 and 190 bases, respectively, indicating that only the proximal signal is used for processing the viral mRNA (results not shown). The poly(A) tail is added after nucleotide 4367, and no detectable mRNA extends beyond this point. The lack of fully protected probe in this experiment confirms the previous observations of the absence of transcripts complementary to the L region in the VX2 carcinoma (5, 12) . A summary of the viral mRNA structures and coordinates is given in Fig. 7 .
DISCUSSION
The domestic rabbit transplantable carcinoma lines harboring active CRPV genomes provide a unique system with which to study the role of a papillomavirus in the establishment and maintenance of epithelial malignancies. The determination of the CRPV genome structure by DNA sequencing (Giri et al., in press) has made it possible to investigate the nature of the proteins encoded by the different viral transcripts detected in the tumors (5, 12, 13) . We initially chose the VX2 carcinoma (7) rather than VX7 (15) because of the greater simplicity of the viral transcription pattern, which is associated with a more acute stage of malignancy (anaplastic character, pulmonary metastases) and identical to the one found in experimentally induced primary carcinoma (13) .
We show here that the two spliced mRNAs most represented in the tumor (5, 12) contain 1,860 and 1,110 bases of CRPV information, respectively, and correspond well to the poly(A)-containing 2.0-and 1.25-kb species described previously. They include a 5'-proximal open reading frame (E6 and E7, respectively), a termination codon, and a second open reading frame originating from the 5' end of El (coding for three N-terminal amino acids) joined to E4. Generally, in eucaryotes, only the first open reading frame of polycistronic mRNAs is translated efficiently (8) . If this is the case here, only E6 and E7 proteins can be translated from the major CRPV transcripts. Yet, we cannot exclude a translation reinitiation event on these transcripts that would yield an E1-E4 fusion polypeptide. agarose gel (6% formaldehyde), transferred to nitrocellulose, and hybridized to 32P-labeled probes as previously described (5) . Lane CR218, Hybridization with 4 x 105 dpm of CR218 Hinfl singlestranded DNA probe (Table 1) . Lane CRPV, hybridization with 8 x 105 dpm of a probe consisting of nick-translated total CRPV DNA (exposure was for 48 h with two screens at -70°C). The sizes of the RNAs are indicated. calculated molecular weight of 19,000. This polypeptide should be compared with the protein encoded from the first ATG, which is 273 residues long and has a calculated molecular weight of 29,700. This full-length E6 protein can be translated from the minor mRNA subclass starting at position 87, which represents less than 5% of the mRNAs transcribed from the E6 region. A set of different M13 probes allowed us to analyze the transcripts along the whole E6 gene, and we found no evidence for splicing in this region. Therefore, two different proteins with a common C terminus can be encoded by the E6 gene. The role of these two proteins and their functional relationship remains to be elucidated. The E6 gene of CRPV is unique among papillomaviruses; it has about twice the coding capacity of other viruses whose genetic organization is known (human papillomaviruses type 1 and 6 and bovine papillomavirus type 1 [BPV1]), and its product shows an intriguing homology with the ATP synthase p-chain family (Giri et al., in press). The repeated motif Cys-X-X-Cys encountered in all papillomaviruses (2) is also present in the CRPV E6 protein. This particular sequence of amino acids is also observed in the E7 gene product which can be translated from the other mRNA species (1,110 bases) . This mRNA is somewhat heterogeneous at its 5' end but can only be translated into the E7 protein, which is 94 residues long (10,500 calculated molecular weight). The cysteine arrangement common to E6 and E7 proteins and their coexpression in carcinomas suggest that they may act on a common target or substrate or use similar pathways. Interestingly, a similar cysteine pattern is observed at the C terminus of simian virus 40 small T antigen, and the mRNA coding for this protein also shows a structure with a 3' untranslated exon (6) . The second exon of the CRPV major mRNAs covers the region of the viral genome between positions 3714 and 4367, where a poly(A) tail is added. This region corresponds to the 3' halves of the E2 and E4 open reading frames (Fig. 7) . If the second open reading frame of the two major mRNAs were translated, it could yield a short E1-E4 protein of 103 amino acids (11,570 daltons).
Our analysis also identified a minor subset of mRNAs comprising three species and transcribed from the E2-E4 region of the genome. Their estimated sizes are, in order of increasing relative amount, 1.8, 2.8, and 4.2 kb. The precise structures of these minor mRNAs have not been unraveled yet, but we assume that they all cover the E2-E4 region from around position 3200 to the polyadenylation site at position 4367, as no transcript was detected beyond this point. To account for their sizes, we would expect these transcripts to contain sequences from the 5' half of the E region. Potentially, these minor populations could at least encode E2 or E4 proteins. The predicted amino acid sequence for E2 has been shown to contain a domain homologous to the mos family of oncogenes (3; Giri et al., in press). In addition, the homologous region in BPV1 (coding for E2, E3, E4, and ES) is essential for transformation of mouse fibroblasts by BPV1. This subgenomic fragment of BPV1 is not active for trans- formation unless a transcriptional enhancer is added (11) . Furthermore, it has recently been shown that the BPV1 E6-E7 region provides a function required for the expression of a fully transformed phenotype of the cells (18) . Similarly, the E2 or E4 gene of CRPV could play a critical role in transformation, but in conjunction with other viral functions, possibly those of E6 and E7 or some regulatory element from the noncoding region of the genome. The isolation of cDNA copies of each gene should allow the study of their respective roles in the transformation process.
The characterization of 5' ends for viral mRNAs permits the tentative localization of promoter elements in the CRPV genome. We have identified two different 5' ends for the largest transcripts. Do they arise from two different promoters positioned in tandem or are they the result of a heterogeneous transcription initiation from a single promoter? Examination of the DNA sequence around the cap sites reveals for each of them a TATA box about 30 nucleotides upstream (TATAT at position 59 for the initiation point at nucleotide 87, and TATAA at position 130 for the initiation point at position 158). This would favor the hypothesis of tandem promoters. Such a situation has already been described for cellular genes such as the mouse a-amylase (19) or human c-myc (9) No CPRV early proteins expressed in the carcinomas have been characterized so far, although some of the mRNAs are expressed at reasonable levels (roughly 20 copies per cell for the E7 mRNA) and found associated with polysomes (13) . Three reasons can be evoked to explain the failure to detect unambiguously a CRPV "E protein" up to now. First, the translation efficiency of the mRNA may be low, and thus the protein is present in trace amounts; second, the early gene products may be very labile and their synthesis retricted to a particular phase of the cell cycle; and third, the viral proteins in their native form may be weakly, if at all, immunogenic, which would impair their detection with antisera from tumor-bearing animals. Overcoming these difficulties will certainly require much more work, but it is now possible to define precisely some of the CRPV proteins to look for.
